Fertilo is a fertility method that uses stem cells to mature human eggs outside the body — and the first baby conceived using this method was just born:
The first baby conceived using a revolutionary fertility method known as Fertilo has been born at the Santa Isabel Clinic in Lima, Peru.
Developed by Gameto, a female-led biotech company, the Fertilo technique uses ovarian support cells (OSCs) derived from induced pluripotent stem cells (iPSCs) to mimic the natural egg maturation process outside the body.
Unlike traditional IVF, Fertilo avoids 80% of the hormone injections and reduces the treatment cycle duration to just three days, making it faster, safer, and less invasive.
Gameto’s CEO, Dr. Dina Radenkovic, hailed the achievement as a “turning point in reproductive health,” emphasizing how the method alleviates physical and emotional strain often associated with conventional IVF. The Fertilo technique has already gained regulatory approval in several countries, including Australia, Japan, and Mexico, with plans for Phase 3 trials in the US.
For the mother of the first Fertilo baby, the innovative approach made the journey to parenthood less stressful and more accessible, offering hope to millions of families worldwide.
